Guadeloupe
- Přehled
- Prevalence obezity
- Komorbidity
- Zásady (k dispozici pouze v angličtině)
- Contextual factors
Načítání dat – čekejte prosím
Prevalence obezity
Stáhnout zprávu
Zpráva shrnuje nejnovější grafiku pro tuto zemi. Pokud chcete vytvořit vlastní zprávu na základě vybrané grafiky, jednoduše klepněte na tlačítko Přidat do vlastního PDF pod grafikou, kterou chcete použít.Komorbidity
Rakovina jícnu
Rakovina prsu
Rakovina tlustého střeva a konečníku
Rakovina slinivky břišní
Rakovina žlučníku
Rakovina ledvin
Rakovina dělohy
Zvýšená hladina glukózy v krvi nalačno
Prevalence diabetu
Ovarian Cancer
Leukemia
Liver & bile duct cancer
Mulitple Myeloma
Non Hodgkin Lymphoma
Thyroid Cancer
Stáhnout zprávu
Zásady (k dispozici pouze v angličtině)
Contextual factors
Prevalence obezity
Dospělí, 2007-2008
Typ průzkumu: | Naměřené |
Věk: | 15+ |
Velikost vzorku: | 602 |
Pokrytá oblast: | Národní |
Reference: | Daigre J-L, et al. The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: The PODIUM survey. Diabetes Metab (2012), http://dx.doi.org/10.1016/j.diabet.2012.03.008 |
Poznámky: | Small sample size |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Rakovina jícnu
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Indicence per 100,000 |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Indicence per 100,000 |
Muži, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Ženy, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Rakovina prsu
Ženy, 2022
Věk: | 20 |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Rakovina tlustého střeva a konečníku
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Muži, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Ženy, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Rakovina slinivky břišní
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Muži, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Ženy, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Rakovina žlučníku
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Indicence per 100,000 |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Indicence per 100,000 |
Muži, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Ženy, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Rakovina ledvin
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Muži, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Ženy, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Rakovina dělohy
Ženy, 2022
Věk: | 20+ |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Ženy, 2020
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2139 |
Definice (k dispozici pouze v angličtině): | Age-standardized indicence rates per 100 000 |
Zvýšená hladina glukózy v krvi nalačno
Muži, 2014
Reference: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A869?lang=en |
Definice (k dispozici pouze v angličtině): | Age Standardised % raised fasting blood glucose (>= 7.0 mmol/L or on medication). |
Ženy, 2014
Reference: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A869?lang=en |
Definice (k dispozici pouze v angličtině): | Age Standardised % raised fasting blood glucose (>= 7.0 mmol/L or on medication). |
Prevalence diabetu
Dospělí, 2017
Reference: | Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org |
Definice (k dispozici pouze v angličtině): | Diabetes age-adjusted comparative prevalence (%). |
Ovarian Cancer
Ženy, 2022
Věk: | 20+ |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Leukemia
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Leukemia
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Liver and intrahepatic bile duct Cancer
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Multiple Myeloma
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Indicence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Indicence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Non Hodgkin Lymphoma
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Pokud není uvedeno jinak, nadváha znamená BMI mezi 25 a 29,9 kg/m², obezita znamená BMI vyšší než 30 kg/m². |
Thyroid Cancer
Muži, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Ženy, 2022
Věk: | 20+ |
Pokrytá oblast: | Národní |
Reference: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Definice (k dispozici pouze v angličtině): | Incidence per 100,000 |
Policies, Interventions and Actions
Contextual factors
Disclaimer: These contextual factors should be interpreted with care. Results are updated as regularly as possible and use very specific criteria. The criteria used and full definitions are available for download at the bottom of this page.
Tap on a tick to find out more about policies influencing this factor.
Labelling
Is there mandatory nutrition labelling? | Absent |
Front-of-package labelling? | Absent |
Back-of-pack nutrition declaration? | Absent |
Color coding? | Absent |
Warning label? | Absent |
Regulation and marketing
Are there fiscal policies on unhealthy products? | Present |
Tax on unhealthy foods? | Absent |
Tax on unhealthy drinks? | Present |
Are there fiscal policies on healthy products? | Absent |
Subsidy on fruits? | Absent |
Subsidy on vegetables? | Absent |
Subsidy on other healthy products? | Absent |
Mandatory limit or ban of trans fat (all settings)? | Absent |
Mandatory limit of trans fats in place (all settings)? | Absent |
Ban on trans-fats or phos in place (all settings)? | Absent |
Are there any mandatory policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
Mandatory restriction on broadcast media? | Absent |
Mandatory restriction on non-broadcast media? | Absent |
Voluntary policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
Are there mandatory standards for food in schools? | Absent |
Are there any mandatory nutrient limits in any manufactured food products? | Absent |
Nutrition standards for public sector procurement? | Absent |
Political will and support
National obesity strategy or nutrition and physical activity national strategy? | Absent |
National obesity strategy? | Absent |
National childhood obesity strategy? | Absent |
Comprehensive nutrition strategy? | Absent |
Comprehensive physical activity strategy? | Absent |
Evidence-based dietary guidelines and/or RDAs? | Absent |
National target(s) on reducing obesity? | Absent |
Guidelines/policy on obesity treatment? | Absent |
Promotion of breastfeeding? | Absent |
Monitoring and surveillance
Monitoring of the prevalence and incidence for the main obesity-related NCDs and risk factors? | Present |
Within 5 years? | Absent |
Governance and resource
Multi-sectoral national co-ordination mechanism for obesity or nutrition (including obesity)? | Absent |
Key
Present
Present (voluntary)
Incoming
Absent
Unknown
Last updated November 27, 2022
Download contextual factors as a PDF Contextual factors definitions